JP2006500032A5 - - Google Patents

Info

Publication number

JP2006500032A5

JP2006500032A5 JP2004538310A JP2004538310A JP2006500032A5 JP 2006500032 A5 JP2006500032 A5 JP 2006500032A5 JP 2004538310 A JP2004538310 A JP 2004538310A JP 2004538310 A JP2004538310 A JP 2004538310A JP 2006500032 A5 JP2006500032 A5 JP 2006500032A5

Authority

JP

Japan

Prior art keywords

nfat

receptor

antibody

seq

activated receptor

Prior art date

2003-09-19

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108020003175 receptors Proteins 0.000 claims 38
• 102000005962 receptors Human genes 0.000 claims 36
• 238000000034 method Methods 0.000 claims 11
• 230000003213 activating effect Effects 0.000 claims 10
• 239000002773 nucleotide Substances 0.000 claims 10
• 125000003729 nucleotide group Chemical group 0.000 claims 10
• 229920001184 polypeptide Polymers 0.000 claims 10
• 102000004196 processed proteins & peptides Human genes 0.000 claims 10
• 108090000765 processed proteins & peptides Proteins 0.000 claims 10
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 8
• 239000005557 antagonist Substances 0.000 claims 8
• 239000012634 fragment Substances 0.000 claims 7
• 210000001124 body fluid Anatomy 0.000 claims 6
• 239000010839 body fluid Substances 0.000 claims 6
• 239000003814 drug Substances 0.000 claims 6
• 108020004414 DNA Proteins 0.000 claims 5
• 125000003275 alpha amino acid group Chemical group 0.000 claims 5
• 201000010099 disease Diseases 0.000 claims 5
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 4
• 102000004127 Cytokines Human genes 0.000 claims 4
• 108090000695 Cytokines Proteins 0.000 claims 4
• 238000004519 manufacturing process Methods 0.000 claims 4
• 108091033319 polynucleotide Proteins 0.000 claims 4
• 102000040430 polynucleotide Human genes 0.000 claims 4
• 239000002157 polynucleotide Substances 0.000 claims 4
• 238000013518 transcription Methods 0.000 claims 4
• 230000035897 transcription Effects 0.000 claims 4
• 238000013519 translation Methods 0.000 claims 4
• 239000000556 agonist Substances 0.000 claims 3
• 239000000427 antigen Substances 0.000 claims 3
• 102000036639 antigens Human genes 0.000 claims 3
• 108091007433 antigens Proteins 0.000 claims 3
• 239000003795 chemical substances by application Substances 0.000 claims 3
• 229940079593 drug Drugs 0.000 claims 3
• 239000013604 expression vector Substances 0.000 claims 3
• 230000001939 inductive effect Effects 0.000 claims 3
• 230000003449 preventive effect Effects 0.000 claims 3
• 239000002464 receptor antagonist Substances 0.000 claims 3
• 229940044551 receptor antagonist Drugs 0.000 claims 3
• 229940124597 therapeutic agent Drugs 0.000 claims 3
• 241000124008 Mammalia Species 0.000 claims 2
• 241001465754 Metazoa Species 0.000 claims 2
• 239000004480 active ingredient Substances 0.000 claims 2
• 150000001413 amino acids Chemical class 0.000 claims 2
• 230000000692 anti-sense effect Effects 0.000 claims 2
• 239000000356 contaminant Substances 0.000 claims 2
• 239000012530 fluid Substances 0.000 claims 2
• 208000026278 immune system disease Diseases 0.000 claims 2
• 239000000018 receptor agonist Substances 0.000 claims 2
• 229940044601 receptor agonist Drugs 0.000 claims 2
• 238000012216 screening Methods 0.000 claims 2
• 208000023275 Autoimmune disease Diseases 0.000 claims 1
• 102000053642 Catalytic RNA Human genes 0.000 claims 1
• 108090000994 Catalytic RNA Proteins 0.000 claims 1
• 241000282412 Homo Species 0.000 claims 1
• 206010020751 Hypersensitivity Diseases 0.000 claims 1
• 108010018525 NFATC Transcription Factors Proteins 0.000 claims 1
• 102000002673 NFATC Transcription Factors Human genes 0.000 claims 1
• 108091030071 RNAI Chemical class 0.000 claims 1
• 230000009471 action Effects 0.000 claims 1
• 208000026935 allergic disease Diseases 0.000 claims 1
• 230000007815 allergy Effects 0.000 claims 1
• 230000000890 antigenic effect Effects 0.000 claims 1
• 208000006673 asthma Diseases 0.000 claims 1
• 230000008827 biological function Effects 0.000 claims 1
• 230000000903 blocking effect Effects 0.000 claims 1
• 230000001413 cellular effect Effects 0.000 claims 1
• 238000012217 deletion Methods 0.000 claims 1
• 230000037430 deletion Effects 0.000 claims 1
• 230000000694 effects Effects 0.000 claims 1
• 230000009368 gene silencing by RNA Effects 0.000 claims 1
• 230000028993 immune response Effects 0.000 claims 1
• 208000027866 inflammatory disease Diseases 0.000 claims 1
• 230000003993 interaction Effects 0.000 claims 1
• 230000002452 interceptive effect Effects 0.000 claims 1
• 239000003446 ligand Substances 0.000 claims 1
• 230000001404 mediated effect Effects 0.000 claims 1
• 108091092562 ribozyme Proteins 0.000 claims 1
• 230000009261 transgenic effect Effects 0.000 claims 1
• 230000007704 transition Effects 0.000 claims 1